Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)

Jiangsu CoWin Biotech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 16, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,053	3,180	3,429	3,314	-	-
Market Cap Growth	0.76%	-7.26%	3.44%	-	-	-
Enterprise Value	2,483	2,576	2,245	2,963	-	-
Last Close Price	27.77	28.61	30.55	29.10	-	-
PE Ratio	-	-	-	20.81	-	-
Forward PE	-	21.80	21.80	-	-	-
PS Ratio	18.26	25.26	20.01	6.35	-	-
PB Ratio	2.17	2.14	2.04	1.85	-	-
P/TBV Ratio	2.28	2.25	2.10	1.90	-	-
P/FCF Ratio	-	-	-	474.27	-	-
P/OCF Ratio	-	-	-	30.87	-	-
EV/Sales Ratio	14.85	20.46	13.10	5.68	-	-
EV/EBITDA Ratio	-	-	-	15.62	-	-
EV/EBIT Ratio	-	-	-	16.80	-	-
EV/FCF Ratio	-19.31	-	-	424.05	-	-
Debt / Equity Ratio	0.02	0.02	0.02	0.02	0.07	-
Debt / EBITDA Ratio	-	-	-	0.20	0.27	-
Debt / FCF Ratio	-	-	-	5.84	1.99	-
Asset Turnover	0.10	0.07	0.09	0.40	0.62	0.88
Inventory Turnover	1.92	1.61	1.60	3.77	3.34	2.52
Quick Ratio	9.07	9.24	12.29	16.79	6.59	14.27
Current Ratio	14.33	9.92	12.78	17.46	7.25	15.36
Return on Equity (ROE)	-9.71%	-10.20%	-4.83%	14.58%	26.16%	45.05%
Return on Assets (ROA)	-6.53%	-6.93%	-4.61%	8.47%	14.95%	27.43%
Return on Invested Capital (ROIC)	-25.59%	-25.25%	-24.73%	49.24%	67.26%	154.80%
Return on Capital Employed (ROCE)	-11.40%	-12.40%	-8.00%	9.50%	22.30%	27.70%
Earnings Yield	-4.51%	-4.94%	-2.46%	4.81%	-	-
FCF Yield	-4.21%	-5.08%	-4.99%	0.21%	-	-
Dividend Yield	-	-	-	1.49%	-	-
Payout Ratio	-	-	-	-	-	30.12%
Buyback Yield / Dilution	9.06%	0.93%	-21.20%	-10.07%	-20.59%	-29.55%
Total Shareholder Return	9.06%	0.93%	-21.20%	-8.58%	-20.59%	-29.55%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.